Clinical Trials Directory

Trials / Completed

CompletedNCT01583634

Accuracy of Oximeters With Hypoxia and Methemoglobin or Carboxyhemoglobin

Status
Completed
Phase
Study type
Observational
Enrollment
9 (actual)
Sponsor
Mespere Lifesciences Inc. · Industry
Sex
All
Age
21 Years – 49 Years
Healthy volunteers
Accepted

Summary

Accuracy of the oximeter.

Detailed description

The conventional pulse oximeter has been a standard in clinical care for non-invasive hemodynamic monitoring, which only measures the arterial blood oxygenation. There are many clinical situations where tissue hypoxia may exist despite normal values obtained by conventional pulse oximeter. This can be cause by inadequate monitoring of oxygen demand (i.e. venous oxygen saturation) of the tissues. The existing method for venous blood oxygenation monitored is either through an invasive fiber optic catheter, or intermittently by blood sampling and CO-oximetry. However, catheterization can be costly and can include inherent risks. Therefore, due to the inherent risks of catheterization, venous oximetry is limited only to those critically ill patients. The clinical application of venous oximetry is numerous, including severe sepsis and septic shock, severe trauma and hemorrhagic shock, and heart failure and cardiac arrest. More complete information on patient hemodynamics can be provided by non-invasively monitoring of venous blood oxygenation.

Conditions

Interventions

TypeNameDescription
DEVICEMespere OximeterMespere oximeter provides non-invasive venous blood oxygen saturation.
DEVICERadiometer OSM-3 Co-OximeterOSM-3, a Radiometer manufactured hemoximeter, is intended for the photometric determination of hemoglobin.

Timeline

Start date
2014-09-01
Primary completion
2014-09-01
Completion
2014-10-01
First posted
2012-04-24
Last updated
2014-10-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01583634. Inclusion in this directory is not an endorsement.